Neoadjuvant Chemotherapy With the Angiogenesis Inhibitor Bevacizumab for Locally Advanced Cervical Cancer.

MLA

Baek, Sunhwa, et al. “Neoadjuvant Chemotherapy With the Angiogenesis Inhibitor Bevacizumab for Locally Advanced Cervical Cancer.” In Vivo (Athens, Greece), vol. 38, no. 6, Nov. 2024, pp. 3068–77. EBSCOhost, https://doi.org/10.21873/invivo.13791.

APA

Baek, S., Noh, K.-W., Zhao, Y., Schoemig-Markiefka, B., Ratiu, D., Domroese, C., Mallmann, M., Mallmann, P., & Pilch, H. (2024). Neoadjuvant Chemotherapy With the Angiogenesis Inhibitor Bevacizumab for Locally Advanced Cervical Cancer. In Vivo (Athens, Greece), 38(6), 3068–3077. https://doi.org/10.21873/invivo.13791

Chicago

Baek, Sunhwa, Ka-Won Noh, Yue Zhao, Birgid Schoemig-Markiefka, Dominik Ratiu, Christian Domroese, Michael Mallmann, Peter Mallmann, and Henryk Pilch. 2024. “Neoadjuvant Chemotherapy With the Angiogenesis Inhibitor Bevacizumab for Locally Advanced Cervical Cancer.” In Vivo (Athens, Greece) 38 (6): 3068–77. doi:10.21873/invivo.13791.